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Biobanks in the United States: How to Identify
an Undefined and Rapidly Evolving Population
Gregory J. Boyer,1 Warren Whipple,2 R. Jean Cadigan,2 and Gail E. Henderson2
As part of a larger organizational study, we sought to survey biobanks in the United States. However, we
encountered two problems with this population. First, no common definition of biobanks exists. Second, no
census is available of these facilities from which to sample in order to implement a survey. In light of these
problems, we employed a multifaceted approach using electronic searches of PubMed, RePORTER, and Google.
In addition, we systematically searched for biobanks housed within universities that have NIH-designated
Clinical and Translational Science Awards (CTSA). We expanded this part of the search by looking for biobanks
among all members of the American Association of Medical Colleges (AAMC). Finally, we added banks to our
database found previously by other researchers and banks found via correspondence with our colleagues. Our
search strategy produced a database of 624 biobanks for which we were able to confirm contact information in
order to conduct our online survey. Another 140 biobanks were identified but did not respond to our requests to
confirm their existence or contact information. In order to maximize both the uniqueness of banks found and the
greatest return on effort for each search, we suggest targeting resources that are already organized. In our work,
these included the CTSA, AAMC, and part of the Google searches. We contend that our search provides a model
for analysis of new fields of research and/or rapidly evolving industries. Furthermore, our approach demon-
strates that with the appropriate tools it is possible to develop a systematic and comprehensive database to
investigate undefined populations.
Introduction
The proliferation of large-scale genomic and gene–environment studies has increasingly relied on ‘‘bio-
banks’’ to collect, store, and oversee the distribution of
specimens and data. Often supplanting traditional researcher–
participant relationships, these organizations work to en-
hance biomedical research as they balance the interests of
specimen and data contributors, researchers, and other
stakeholders. In response to the dearth of empirical data on
biobank policies and governance structures, our research
team undertook an organizational study of biobanks in the
United States, funded by the National Human Genome
Research Institute (NHGRI). We conducted in-depth case
studies of selected biobanks in the United States, con-
structed a database of biobanks, and administered an online
survey.
The ultimate goal for survey research is to draw a repre-
sentative sample of a study population. In the case of bio-
banks, however, two immediate problems posed significant
barriers to accomplishing this goal. We describe these
problems, the measures we took to address them, and offer
recommendations for other researchers working with simi-
larly undefined and rapidly evolving populations.
The first problem is one of naming/identification. A
variety of entities with many different names collect and
store biological specimens.1–3 For example, ‘‘biobank,’’ ‘‘bio-
repository,’’ ‘‘specimen bank/repository,’’ and ‘‘tissue bank/
repository’’ are just some of the terms used to describe these
entities. We use the term ‘‘biobank’’ in this article. We also
limited the scope of our search and our use of the term
‘‘biobank’’ to our research interests: organizations that ac-
quire and store genetically identifiable human biospecimens
and associated data for future research and sharing pur-
poses. Examples of biobanks include: (1) commercial entities
that sell and/or collect specimens; (2) university-based col-
lections, including research cores; (3) small collections, cre-
ated by an investigator or group of investigators whose
ongoing research uses stored specimens; (4) government-
funded or facilitated networks that house centralized speci-
men repositories; and (5) nonprofit disease advocacy orga-
nizations that store samples relating to a specific condition
or population. These examples are neither exhaustive nor
mutually exclusive.
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The second problem is the lack of a reliable biobank cen-
sus. Whatever term is used, the total number of biobanks is
unknown. In the late 1990s, RAND researchers attempted to
catalog collections of stored tissue specimens (not biobanks
per se). They conservatively estimated that over 307 million
specimens from more than 178 million cases were stored in
the United States.4 Since the RAND study, tissue collections
and biobanks have proliferated in many settings, further
complicating any census or comprehensive list from which to
sample. Thus, to accomplish our research goals, we needed
to develop a strategy for cataloging these heterogeneous
entities with no agreed-upon definition or known census.
Methods
Given the problems noted above, we adopted a multifac-
eted approach similar to that employed by RAND to build a
database of US biobanks. RAND began with a literature re-
view for information on tissue and DNA banks; searched
NIH’s CRISP database (now named RePORTER), RAND’s
proprietary RaDiUS database, and the Internet; and used
communication with knowledgeable sources.4
Using search terms that included all names commonly
used for biobanks, we conducted a systematic search of ar-
ticles listed in PubMed for the year 2010; a search of abstracts
of currently funded federal grants from NIH’s RePORTER
database for 2010; and a systematic Google search which
included both initial and follow-up searches of lists and
directories of biobanks appearing in the initial search. In
addition, because a significant portion of medical research is
sponsored by medical institutions and research institutes,
and more recently by NIH-sponsored Clinical and Transla-
tional Science Awards (CTSAs), we conducted searches on
American Association of Medical Colleges (AAMC) member
websites and on CTSA websites. Lastly, personal commu-
nication with other investigators provided information about
additional US biobanks.
Search procedures
PubMed and NIH RePORTER searches. The PubMed and
NIH RePORTER searches began with keyword finds using
the nested Boolean strings described in Table 1. We con-
structed the search strings to account for the fact that some
terms imply the storage of specimens (e.g., ‘‘biorepository’’)
while other terms do not (e.g., ‘‘collection’’). We included
genomic criteria in our search strings because our survey
was specifically interested in the use of biobanks to facilitate
genomic research.
The PubMed keyword find was conducted in February
2011, applied to titles and abstracts, and limited to articles
published in English in 2010; it resulted in 1126 ‘‘hits.’’ The
NIH RePORTER keyword find was conducted in December
2010, applied to titles and abstracts and scientific terms, and
limited to active projects during fiscal year 2010; it resulted in
3333 ‘‘hits.’’ A total of 4459 abstracts resulted from these
‘‘hits.’’
All PubMed and RePORTER abstracts were systematically
reviewed for content mentioning the use, management, or
creation of any biobank. A software program highlighted all
terms from the ‘‘Bank String’’ and ‘‘Collection String’’ in
Table 1 so that abstracts only using those terms in ways not
relevant to biobanking could be excluded (e.g., ‘‘World
Bank’’). Because of our research interests, we excluded ab-
stracts that only discussed nonhuman specimens or speci-
mens kept outside the US. Any cases not specific about the
kind of specimens or location of storage were included.
Biobanks were only recorded for the study if they were
mentioned by a proper name, or if it was clear from context
they were specifically associated with an organization or
study with a proper name. An example of an abstract citing a
properly named biobank includes ‘‘[Specimens] were suc-
cessfully genotyped in 9483 samples accrued over 4 months
into BioVU, the Vanderbilt University Medical Center DNA
biobank.’’5 Some abstracts only mentioned banked speci-
mens associated with an organization, for example, ‘‘.his-
tologically normal nontumor brain specimens.were
obtained from the University of Iowa Hospital.’’6 If banked
specimens were only mentioned generally in a PubMed ab-
stract, we searched the full-text article using the same
methods and criteria described above, for example, ‘‘.single
nucleotide polymorphisms were investigated through in vitro
(53 human livers from primarily White donors) and in vivo
(26 mainly White or African-American volunteers).’’7
Because we did not have access to the full text of the grants,
if banked specimens were only mentioned generally in an
NIH RePORTER abstract, we did not record the bank.
Google searches. The Google search involved two steps. In
the first step, called ‘‘Google Direct’’, keywords were sear-
ched using the Google search engine. Because Google search
results are vast in number with ranking dependent on word
order, and synonyms and word variations are automatically
included, we did not use the same search strategy as with
PubMed and NIH RePORTER. Instead we conducted six
Google searches, each using one of the following phrases: (1)
biobank, (2) biorepository, (3) specimen bank, (4) specimen
Table 1. PubMed and NIH RePORTER Nested
Boolean Search Strings
First Disjunctive Nesting Level
(Bank String) = bank* OR biobank* OR repositor*
OR biorepositor*
(Collection String) = collection* OR registr* OR database*
OR databank*
(Specimen String) = specimen* OR biospecimen*
OR sample* OR biosample* OR tissue* OR blood*
(Genomic String) = genom* OR gene* OR genetic*
or DNA OR sequence*
Second Conjunctive Nesting Level
(A String) = (Bank String) AND (Genomic String)
(B String) = (Collection String) AND (Specimen String)
AND (Genomic String)
Final Disjunctive Nesting Level
= (A String) OR (B String)
While NIH RePORTER now accepts nested Boolean search strings,
at the time of our search (2010), it did not. NIH RePORTER also does
not allow for the export of more than 15,000 records at one time. To
circumvent these obstacles, we rearranged the nested Boolean strings
into groups that (1) allowed for use of a single Boolean operator per
search, and (2) returned results in batches of less than 15,000. This
required splitting the disjunctive ‘‘genomic string’’ and conjunctively
distributing it across other strings in multiple searches. It also
required including some grants by comparing some results for
overlap by their unique database ID numbers, as well as removing
some duplicate results. The end result was logically equivalent to
using the final nested Boolean string described in Table 1.
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repository, (5) tissue bank, and (6) tissue repository. For each
search, the first 100 ‘‘hits’’ were retrieved and results com-
bined into a single list with duplicates culled by URL,
resulting in a total of 518 page hits. We set Google to return
100 hits per page, but it returned a few more per page. The
combined total was 641 hits across the 6 searches. 123
duplicates were culled resulting in the final total of 518
page hits.
These web pages were reviewed via the same methods
and criteria used for the PubMed and NIH RePORTER ab-
stracts. Google searches did not include genomic search
string terms because we did not want to exclude biobanks
that failed to mention on their websites that they facilitated
genomic research. (This holds true for AAMC and CTSA
searches, described below.)
Many web pages did not describe a single biobank but
served as a listing or directory of biobanks. This led to the
second search, called the ‘‘Google Lists.’’ Any web page that
listed 3 or more apparent biobanks was added to a list of lists
to be reviewed as well. This resulted in 31 lists, with an
average of 34.5 items per list. Most of these lists contained
URL links to further descriptions of a biobank. These web
pages were reviewed further using the same methods and
criteria described above. In cases where only a proper name
of a biobank was listed with no URL link or a broken URL
link, we searched for the proper name of the bank using
Google and reviewed the first five hits for mention of that
bank.
AAMC and CTSA searches. Each member website of the
AAMC member list (137 U.S. Medical Institutions)8 was
searched for biobanks using the terms ‘‘bank,’’ ‘‘repositor,’’
‘‘collection,’’ ‘‘registr,’’ ‘‘databa,’’ ‘‘specimen,’’ or ‘‘sample.’’
We also employed a Google search combining the insti-
tution’s name and the following terms: ‘‘Biobank’’ OR
‘‘Specimen Bank’’ OR ‘‘Tissue Bank’’ OR ‘‘DNA Bank’’ OR
‘‘Biorepository’’ OR ‘‘Specimen Repository’’ OR ‘‘Tissue
Repository’’ OR ‘‘DNA Repository.’’
Using a listing of the then-NIH-awarded CTSAs at 60
universities,9 we searched each CTSA website for direct links
to biobanks using the terms ‘‘core facilities’’ or ‘‘resources:
Core.’’ If a biobank website was not found, the CTSA site
was searched using the following terms: ‘‘repository’’,
‘‘biorepository’’, ‘‘tissue bank’’, and ‘‘specimen storage.’’
Previous research and personal correspondence. Professor
Susan Wolf and colleagues at the University of Minnesota
shared a list of biobanks identified by searching NIH web-
sites and Google collected for a separate research study led
by Gina Johnson and colleagues.10 This information was
treated similar to a list found using Google, using the in-
clusion criteria noted above.
Throughout the database development process, we ob-
tained the names of biobanks from personal communica-
tions, similar to the RAND study. For example, we contacted
CTSA Clinical Research Ethics Core members who com-
prised a ‘‘biobank working group’’ to obtain additional re-
ferrals for biobanks at CTSA institutions. However, since we
did not explicitly search for these banks, we do not include
them in the results section.
Results
Our search strategy produced a database of 624 biobanks
for which we were able to confirm contact information for
recruitment to the online survey. Another 140 biobanks were
identified but did not respond to our requests to confirm
their existence or obtain contact information.
Table 2 shows the search results. The column labeled
‘‘Effort’’ displays the total number of possible sources of
biobanks, or ‘‘hits,’’ for each type of search conducted. Since
all of the medical school websites in the US, all CTSAs, and
the list of biobank names identified by Johnson and collea-
gues. were searched, we provide estimates for effort for those
searches. The total number of biobanks found in each search
is listed in the column labeled ‘‘# Banks Responding.’’ For
example, 1126 PubMed articles identified by the search
produced 56 total biobanks (i.e., confirmed as existing and
having contact information). The column labeled ‘‘Sensitiv-
ity,’’ or the # of Banks divided by the Effort, represents a
‘‘return on investment’’ for each search. Thus, return on in-
vestment from the PubMed search is 5%, or 56/1126.
The ‘‘# Unique Banks’’ column in Table 2 denotes the
number of unique biobanks for each search. The column
entitled ‘‘Unique Banks in Search’’ represents the number of
unique banks divided by the number of banks responding,
as a percent, for each search. Continuing with the PubMed
example, this search provided 18 unique banks, or 32 percent
of all banks identified (18/56). The column entitled ‘‘Unique
Banks/All Banks’’ denotes the total number of banks found
for that entity divided by the total of all banks (624); for
PubMed, this is 3% (18/624).












PubMed 1126 56 5% 18 32% 3% 2%
NIH RePORTER 3300 197 6% 68 35% 11% 2%
Google Direct 518 173 33% 33 19% 5% 6%
Google Lists 1100 327 30% 135 41% 22% 12%
CTSA Search*** 300 57 19% 25 44% 4% 8%
AAMC Search**** 685 200 29% 78 39% 13% 11%
Johnson Study 115 78 68% 9 12% 1% 8%
All Sources 7144 624 9% 366 59% 59% 5%
*Effort is roughly equal to things searched (article abstracts, grants abstracts, single web pages).
**‘‘Banks’’ includes only those contacted and confirmed as biobanks.
***Estimate from 60 CTSA universities · 5 pages per university.
****Estimate from 137 medical institutions · 5 pages per institutions.
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The final column in Table 2, labeled ‘‘Unique/Effort,’’
represents the number of unique biobanks found for each
search divided by the total number of banks; for PubMed,
this is 2% (18/1126).
Examining the data in Table 2 shows that the PubMed and
RePORTER searches produced 18 and 68 unique banks, re-
spectively. The sensitivity or return on investment of these
searches was the lowest of all the searches while requiring
the greatest effort. However, the uniqueness of the banks
found within each of the searches denoted in the column
‘‘Unique Banks in Search’’ is relatively high in comparison to
other searches.
The Google searches provided over 150 unique banks for
our database. These searches had a high degree of sensitivity,
but differ with percent uniqueness of each search. That the
‘‘Google Lists’’ had a higher percent unique for each search
is not surprising given these searches included already-
organized lists of entities that would likely fit our definition
of a biobank.
The AAMC and CTSA searches added significantly to our
database with over 100 unique banks and the highest
uniqueness for each search and relatively high sensitivity.
These results are also not surprising given the propensity to
find biobanks in academic settings. Conversely, the Johnson
study provided high sensitivity, but low uniqueness and
percent unique for this search. This is likely due to our dili-
gence in looking for academic and government biobanks in
other searches.
Figures 1 and 2 provide a visual representation of the
uniqueness of each search and the degree of overlap with
other searches. Figure 1, the analog of the ‘‘# Unique Banks’’
column in Table 2, shows the overlap between the searches
where the darkest part of each bar represents the unique
banks (no overlap) of that individual search. The increas-
ingly lighter segments show banks found by one other
search, two other searches, and so on up to five other sear-
ches. Figure 2 shows the same information as a percentage,
the analog of the ‘‘Unique Banks in Search’’ column in Table
2. Again, the darkest, furthest left part of each bar denotes
banks found only using that particular search.
In Figure 3, the darkest, furthest left part of each bar de-
notes the same data as the ‘‘Unique/Effort’’ column of Table
2. The remainder of each bar in Figure 3 represents the
percentage of the overlap for each search with other searches.
For the ‘‘Google Direct’’ search, approximately 11% of bio-
banks found with this search overlapped with one other
search (58/500). (The tables with counts used to create
Figures 1, 2, and 3 are included in Appendix A).
Figure 4 plots the relationship between sensitivity and
uniqueness. As sensitivity increases, uniqueness also in-
creases up to approximately 45%.
Discussion
Two problems persist in identifying a population of bio-
banks to survey. To address the naming problem, we used a
wide variety of keywords in our searches. Those keywords
were read in context in the abstracts and webpages. Ulti-
mately, if the information found online was ambiguous, the
people associated with the collection were contacted and
asked if the collection was a biobank by our definition. To
address the fact that there is no reliable census, we used
multiple search strategies, and carefully recorded the sources
and cross-referenced for overlap so that we could both
identify duplicates and identify the strengths and weak-
nesses of different sources.
Our results suggest that if one hopes to maximize both
uniqueness and sensitivity, one would want to target sear-
ches found in the upper, right-hand quadrant of Figure 4.
None of our searches met this goal. However, the Google
List, AAMC, and CTSA searches came the closest. The
searches were likely so productive because they tap re-
sources that are already organized to find or display bio-
banks. The other searches produced biobanks, but had lower
FIG. 1. Banks and overlap
between searches.
FIG. 2. Banks/Sum for that
search.
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levels of sensitivity and uniqueness. The sensitivity measure
might be biased downward for the PubMed and RePORTER
searches because of the effort/work for both. The Johnson
Study search was highly sensitive but not unique, given the
types of organizations included in this and the AAMC,
CTSA, and Google searches. The Google Direct search fell
somewhat outside the relationship, but was still relatively
sensitive and unique.
It is important to note that a positive relationship persisted
between effort and uniqueness. Putting more effort into searches
provided us with biobanks that we might not have found
otherwise and might have skewed our sample to one par-
ticular kind (academic, commercial, government, nonprofit)
of biobank. While overlap occurs, our diligence in searching
PubMed, RePORTER, and Google for possible biobanks
provided us with a diversity of organizations to survey. In
fact, as Table 2 shows, over half of all biobanks in our da-
tabase (366/624) were found by only one search.
While we were rewarded with greater effort, the two
Google searches provided over 500 banks. The CTSA and
AAMC searches provided over 250 banks. Thus, if time is a
limiting factor, using already-organized and/or easy to obtain re-
sources for searches might provide an adequate list. However,
such a list may have limited diversity given the types of
resources used.
Strategies for future research include narrowing the search
for specific diseases, enlarging the search to include more
years, tracking government investment in biobanks, and/or
increasing the search breadth. These strategies and their re-
spective applications, listed in Table 3, can be used by bio-
bank researchers to network and collaborate with their peers.
Limitations
Each search had limitations. The PubMed and RePORTER
searches were limited to 2010, likely missing more recently
established biobanks. Furthermore, it was limited to infor-
mation from a published article or grant abstract. Some ar-
ticles did not mention a biobank specifically and/or were
vague about the use of specimens. Grant abstracts could also
be vague and were occasionally missing entirely. In addition,
because the RePORTER and CTSA searches are tied to NIH
funding, these searches may have missed biobanks that do
not receive such funding.
The Google search had several limitations. The terms for
the Google search were not identical to those for the PubMed
and RePORTER searches. Furthermore, Google disallowed
strict search parameters. Google is not a static resource; a
search done on a given day will be different than the same
search performed on a subsequent day.
With regard to the CTSA and AAMC searches, there is no
standardized way to list biobanks or to display or advertise
ongoing research on a website. Certain facilities may be bio-
banks, but not captured in our search due to unclear descrip-
tions. This lack of uniformity likely means that these searches
missed biobanks that were not displayed through university
websites. Thus, we were limited to the information available on
the respective websites at the time of our search.
These limitations were addressed by combining different
search strategies, and through seeking additional bank
names from experts and those involved with the develop-
ment of biobanks. In addition, our procedures for recording
details about each biobank allowed us to check for overlap
FIG. 3. Banks/Effort for that
search.
FIG. 4. Percent unique in each search vs.
sensitivity.
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within and across searches. This approach produces data
that can be used to address inevitable selection biases.
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Table 3. Strategies and Applications for Future Work
Strategy Application
1. More Specificity Adding Boolean strings for specifics such as ‘‘prostate cancer’’,
‘‘metabolic syndrome’’, and/or ‘‘African American’’ to our search
would narrow the search based on the investigator’s interest.
The search strategy could be tailored for
specific diseases, conditions, and populations.
2. Additional Years/Track Over Time Repeating our PubMed and RePORTER search strategies for additional
years would provide a window to the growth of biobanks over time.
The remaining searches would be done at predetermined time
intervals. This strategy could be added to strategy number 1.
More years can be added to the search in order
to understand the growth/change of biobanks
over time.
3. Track Government Investment in Biobanks By using RePORTER, public investment in biobanks could be tracked.
This strategy could be combined with strategies 1 and/or 2 above.The search strategy could be tailored to look
specifically at government resources over
time.
4. Greater Breadth Instead of excluding non-human and/or non-U.S. specimens, one
could easily include such specimens in a search. Thus, one would
rely on Google and PubMed, and less on RePORTER, CTSA,
and AAMC. This strategy could be combined with any or all
of the above strategies.
Our search parameters could be changed
to include nonhuman specimens and/or
specimens not housed in the U.S.
(Appendix follows/)
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Appendix A: Counts for Figures 1, 2, and 3
Appendix Table A1. Counts for Figure 1
Overlap with Other Searches
0 1 2 3 4 5 Sum
PubMed 18 4 16 9 7 2 56
NIH RePORTER 68 40 47 25 15 2 197
Google Direct 33 54 41 29 14 2 173
Google Lists 135 80 61 33 16 2 327
CTSA Search 25 19 5 5 3 0 57
AAMC Search 78 43 40 25 12 2 200
Johnson Study 9 14 18 22 13 2 78
Numbers in Table are (Banks).
Appendix Table A2. Counts for Figure 2
Overlap with Other Searches
0 1 2 3 4 5 Sum
PubMed 32% 7% 29% 16% 13% 4% 100%
NIH RePORTER 35% 20% 24% 13% 8% 1% 100%
Google Direct 19% 31% 24% 17% 8% 1% 100%
Google Lists 41% 24% 19% 10% 5% 1% 100%
CTSA Search 44% 33% 9% 9% 5% 0% 100%
AAMC Search 39% 22% 20% 13% 6% 1% 100%
Johnson Study 12% 18% 23% 28% 17% 3% 100%
Percentages in Table are (Banks)/(Sum for that Search).
Appendix Table A3. Counts for Figure 3
Overlap with Other Searches
0 1 2 3 4 5 Sum Effort*
PubMed 1.6% 0.4% 1.4% 0.8% 0.6% 0.2% 5% 1126
NIH RePORTER 2.1% 1.2% 1.4% 0.8% 0.5% 0.1% 6% 3300
Google Direct 6.4% 10.4% 7.9% 5.6% 2.7% 0.4% 33% 518
Google Lists 12.3% 7.3% 5.5% 3.0% 1.5% 0.2% 30% 1100
CTSA Search 8.3% 6.3% 1.7% 1.7% 1.0% 0.0% 19% 300**
AAMC Search 11.4% 6.3% 5.8% 3.6% 1.8% 0.3% 29% 685***
Johnson Study 7.8% 12.2% 15.7% 19.1% 11.3% 1.7% 68% 115
*Effort is roughly equal to things searched (article abstracts, grants abstracts, single web pages).
**Estimate from 60 CTSA universities · 5 pages per university.
***Estimate from 137 medical institutions · 5 pages per institution.
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